1. Home
  2. TECH vs ENSG Comparison

TECH vs ENSG Comparison

Compare TECH & ENSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • ENSG
  • Stock Information
  • Founded
  • TECH 1976
  • ENSG 1999
  • Country
  • TECH United States
  • ENSG United States
  • Employees
  • TECH N/A
  • ENSG N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • ENSG Hospital/Nursing Management
  • Sector
  • TECH Health Care
  • ENSG Health Care
  • Exchange
  • TECH Nasdaq
  • ENSG Nasdaq
  • Market Cap
  • TECH 8.3B
  • ENSG 9.6B
  • IPO Year
  • TECH 1989
  • ENSG 2007
  • Fundamental
  • Price
  • TECH $51.52
  • ENSG $165.94
  • Analyst Decision
  • TECH Buy
  • ENSG Buy
  • Analyst Count
  • TECH 12
  • ENSG 7
  • Target Price
  • TECH $70.91
  • ENSG $171.86
  • AVG Volume (30 Days)
  • TECH 2.1M
  • ENSG 330.4K
  • Earning Date
  • TECH 10-29-2025
  • ENSG 10-23-2025
  • Dividend Yield
  • TECH 0.62%
  • ENSG 0.15%
  • EPS Growth
  • TECH N/A
  • ENSG 41.66
  • EPS
  • TECH 0.46
  • ENSG 5.52
  • Revenue
  • TECH $1,219,635,000.00
  • ENSG $4,614,838,000.00
  • Revenue This Year
  • TECH $4.13
  • ENSG $19.59
  • Revenue Next Year
  • TECH $7.56
  • ENSG $10.78
  • P/E Ratio
  • TECH $112.02
  • ENSG $30.04
  • Revenue Growth
  • TECH 5.23
  • ENSG 16.31
  • 52 Week Low
  • TECH $46.01
  • ENSG $118.73
  • 52 Week High
  • TECH $80.95
  • ENSG $174.98
  • Technical
  • Relative Strength Index (RSI)
  • TECH 43.21
  • ENSG 49.09
  • Support Level
  • TECH $50.96
  • ENSG $165.58
  • Resistance Level
  • TECH $54.62
  • ENSG $169.78
  • Average True Range (ATR)
  • TECH 1.90
  • ENSG 3.39
  • MACD
  • TECH -0.34
  • ENSG -1.55
  • Stochastic Oscillator
  • TECH 13.01
  • ENSG 25.10

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About ENSG The Ensign Group Inc.

Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.

Share on Social Networks: